Lutetium-177 (Lu-177) Chloride Solution (n.c.a.)

Non-carrier-added GMP-grade radiochemical for clinical and non-clinical research purposes

High purity non-carrier-added Lutetium-177 (Lu-177) Chloride solution in GMP grade for your research activities. The radiochemical solution is used for the preparation of radiolabeled compounds in the research context.

Request further information now!

Key Features

PLEASE NOTE: The product is not intended for direct use in humans and has not been registered as a pharmaceutical product.

Lutetium-177 Detail Information

Lutetium-177 is a β-emitter with a half-life of 6.65 days. It can be produced via two different routes, direct by irradiation of Lutetium-176 for carrier-added or as in our case indirect by irradiation of Ytterbium-176 for non-carrier-added (n.c.a.) form. Lu-177 decays by emission of beta radiation (β: 148.8 keV) and gamma radiation (γ: 208 keV – 10.4 % abundance) to Hafnium-177.


Lutetium-177 has become more and more important over the last years as a substance used in many new radiopharmaceuticals, especially for cancer therapy. In combination with diagnostic [68Ga]-based-agents, it is now the main therapeutic nuclide for theranostic approaches, such as with DOTA-conjugated compounds for binding to the prostate specific membrane antigen (PSMA). Numerous further radiotherapeutic agents are currently under development for several types of cancer.

GMP Quality and Safety Standards

Lutetium-177 Chloride solution is produced in a state-of-the-art GMP production facility. The high purity of our product enables pre-calibration up to ten days. Enhanced vial shielding is used to protect users of unnecessary exposure in accordance with the ALARA principle.

We provide Lu-177 Chloride ([177Lu]LuCI3) as a sterile solution. It is to be used only for in vitro-radiolabeling of carrier molecules. It is not meant for direct application to humans.

U.S. DMF Type II

Eckert & Ziegler holds a Type II DMF (#038043) with the U.S. FDA.
The product has not been registered as a radiopharmaceutical in the European Union. In the USA, it is regarded as a drug substance.

Flexible Dispensing

We dispense your required volume of sterile Lutetium-177 Chloride solution up to 3 mL in V-vials or up to 5 mL in a 10R-glass flat bottom vial with activities up to 200 GBq (5.4 Ci)

Production Capacity and Raw Material

Eckert & Ziegler implemented efficient processes and resource allocation measures to ensure uninterrupted production and consistent supply to meet the growing global demand for Lu-177 Chloride (n.c.a.). Moreover, we are currently establishing our own supply of the indispensable precursor material Ytterbium-176, including an efficient recycling process.

Reliable Delivery

A broad international logistics network enables us to deliver Lutetium-177 Chloride worldwide within four business days. Close proximity to international transportation hubs, a global network of partners and the experienced team ensure optimal logistics.

Calibration Solution

We provide a range of PTB and NIST-traceable Lutetium-177 calibrated solutions. In cooperation with the Eckert & Ziegler Nuclitec we also provide a Lu-177 calibration solution certified by the DAkkS. All our solutions are available on request.

Method and specifications

Lutetium-177 Chloride Solution is produced in high quality non-carrier-added form by irradiation of Ytterbium-176 and subsequent separation of Lu-177 in our radiochemical facility. This process achieves highest purity.

Product [177Lu]Lutetium Chloride solution (clear and colorless)
Active Ingredient [177Lu]Lutetium Chloride, 40 GBq/mL
Excipients Hydrochloric Acid (0.04 mol/L)
Chemical Form [177Lu]LuCl3 in 0.04 mol/L hydrochloric acid solution
Activity As requested 4 – 200 GBq per vial (activity tolerance ± 10%)
Radiochemical purity > 99.0 % [177Lu]Lutetium as Lu3+
Radionuclide purity

≥ 99,9%
[175Yb]Ytterbium ≤ 0.1%
[177mLu]Lutetium ≤ 0.07% 
All other radionuclide impurities ≤ 0.01%

pH 1 – 2
Sterility Sterile
Delivery time Within 4 business days worldwide

CDMO Services and GMP Suites

Eckert & Ziegler also provides a wide range of CDMO services, including the development of radiolabeling and quality control protocols for your Lutetium-based products. With our global network of GMP suites (EMEA, AMERICAS, APAC) we give access to state-of-the-art infrastructure including logistics and a highly experienced staff.

Product specific questions?

Eckert & Ziegler
Radiopharma GmbH
Robert-Rössle-Straße 10
13125 Berlin

+49 30 94 10 84 280
+49 30 94 10 84 470
The Medical Bulletin Subscribe and stay updated

Are you interested in receiving the latest news on our products and recent developments? Do you want to stay updated regarding upcoming events? Our newsletter will be sent regularly and you can unsubscribe anytime.

Email Lists (please select at least one)


WordPress Cookie Plugin by Real Cookie Banner